Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 July, 2018 06:55 IST
Cipla receives final approval for generic Viread tablets
Source: IRIS | 29 Jan, 2018, 10.08AM
Comments  |  Post Comment

Cipla, a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients, announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Tenofovir Disoproxil Fumarate Tablets, 300mg, from the United States Food and Drug Administration (USFDA) to market a generic version of Gilead Sciences' Viread Tablets, 300mg.
 
Cipla's Tenofovir Disoproxil Fumarate Tablets, 300mg, are AB-rated generic equivalents of Gilead Sciences' Viread Tablets, 300mg, and are indicated in combination with other antiretroviral (ARV) agents for the treatment of HIV -1 infection in adults and paediatric patients 12 years of age and older. Cipla is excited to add this important antiretroviral product to its growing portfolio of ARVs in the U.S.

The product will be available for commercial shipment in the U.S. immediately. Viread Tablets, 300mg, had U.S. sales of approximately USD 72SM for the 12-month period ending November 2017, as reported by IMS Health.

Shares of the company gained Rs 4.25, or 0.68%, to trade at Rs 625.55. The total volume of shares traded was 11,963 at the BSE (9.59 a.m., Monday).



Cipla Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Yes Bank partners with 10 smart cities to tackle development challenges - 19-Jul-2018 17:36
Govt to infuse capital worth Rs 17.9 bn in Allahabad Bank - 19-Jul-2018 16:17
Trigyn Technologies wins contract from U.S. Army Picatinny Arsenal - 19-Jul-2018 16:11
Kotak Mahindra Bank quarterly net climbs 12.3% to Rs 10.25 bn - 19-Jul-2018 15:58
Bajaj Finance quarterly profit surges 83% - 19-Jul-2018 15:32
Tata Motors bags order to supply electric vehicles to Cognizant - 19-Jul-2018 13:19
Infosys Foundation signs accord with Bangalore Metro - 19-Jul-2018 11:49
Lupin receives tentative USFDA approval for generic Tadalafil tablets - 19-Jul-2018 11:34
Zydus Cadila gets USFDA's final nod for Piroxicam capsules - 19-Jul-2018 10:26
MCX takes preventive measures against technical glitches - 19-Jul-2018 10:19
Tata Power launches electric vehicle charging stations in Hyderabad - 18-Jul-2018 15:45
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer